Herbas VPB

Print
EN | LT
LT - Cistinės fibrozės transmembraninio laidumo reguliatoriaus baltymų moduliatoriai ir jų naudojimo būdai
EN - MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 213/71 (2006.01)
C07D 215/36 (2006.01)
C07D 231/56 (2006.01)
C07D 401/12 (2006.01)
C07D 235/28 (2006.01)
C07D 471/04 (2006.01)
C07D 213/64 (2006.01)
C07C 311/45 (2006.01)
A61P 11/00 (2006.01)
A61K 31/4709 (2006.01)
European patent
(11) Number of the document 3681864
(13) Kind of document T
(96) European patent application number 18779798.0
Date of filing the European patent application 2018-09-13
(97) Date of publication of the European application 2020-07-22
(45) Date of publication and mention of the grant of the patent 2020-10-28
(46) Date of publication of the claims translation 2021-02-25
PCT application
(86) Number PCT/IB2018/057020
Date 2018-09-13
PCT application publication
(87) Number WO 2019/053634
Date 2019-03-21
Priority applications
(30) Number Date Country code
201762558430 P 2017-09-14 US
201762608846 P 2017-12-21 US
Inventors
(72)
ALTENBACH, Robert J., US
BOGDAN, Andrew, US
COUTY, Sylvain, FR
DESROY, Nicolas, FR
GFESSER, Gregory A., US
HOUSSEMAN, Christopher Gaėtan, FR
KYM, Philip R., US
LIU, Bo, US
MAI, Thi Thu Trang, FR
MALAGU, Karine Fabienne, GB
MERAYO MERAYO, Nuria, FR
PICOLET, Olivier Laurent, FR
PIZZONERO, Mathieu Rafaėl, FR
SEARLE, Xenia B., US
VAN DER PLAS, Steven Emiel, BE
WANG, Xueqing, US
YEUNG, Ming C., US
Grantee
(73) Galapagos NV, Generaal De Wittelaan L11/A3, 2800 Mechelen, BE
AbbVie Overseas S.a r.l., 26 Boulevard Royal, 2449 Luxembourg, LU
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Cistinės fibrozės transmembraninio laidumo reguliatoriaus baltymų moduliatoriai ir jų naudojimo būdai
  MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE
Last renewal fee
Payment date Validity (years) Amount
2021-09-07 4 92.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2022-09-13